Livzon Pharmaceutical Group Inc.  

(Public, SHE:200513)   Watch this stock  
Find more results for 200513
39.63
+0.13 (0.33%)
May 17 - Close
SHE real-time data - Disclaimer
Currency in HKD
Range 39.40 - 40.09
52 week 16.81 - 41.80
Open 39.41
Vol. 125,801.00
Mkt cap 11.48B
P/E 19.69
EPS 2.01
Shares 289.66M
Aug 12, 2013
Q2 2013 Livzon Pharmaceutical Group Inc Earnings Release Add to calendar
Jun 21, 2013
Livzon Pharmaceutical Group Inc Annual Shareholder Meeting - 9:30AM GMT+8 - Add to calendar
Apr 20, 2013
Q1 2013 Livzon Pharmaceutical Group Inc Earnings Release
Apr 17, 2013
丽珠集团:关于境内上市外资股转换上市地以介绍方式在香港联合交易所有限公司主板上市及挂牌交易事项进展的提示性公告
Mar 26, 2013
丽珠集团:关于召开2012年度股东大会通知
Mar 26, 2013
丽珠集团:对外投资公告
Mar 23, 2013
Q4 2012 Livzon Pharmaceutical Group Inc Earnings Release
Mar 15, 2013
Livzon Pharmaceutical Group Inc at Macquarie B/A-to-H Share Corporate Day
Mar 9, 2013
丽珠集团:独立董事对公司2012年度控股股东及其他关联方资金占用及对外担保事项的专项说明和独立意见
Mar 9, 2013
丽珠集团:关于公司2012年度控股股东及其他关联方占用资金情况的专项说明
  

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin 14.10% 12.05%
Operating margin 15.65% 13.15%
EBITD margin - 15.91%
Return on average assets 10.30% 9.28%
Return on average equity 19.10% 15.10%
Employees 5,587 -
Carbon Disclosure Rating - -

Address

Livzon Mansion No.132 Guihua North Road, Gongbei Gongbei District
ZHUHAI, GNG 519020
China
+86-756-8135888 (Phone)
+86-756-8886002 (Fax)

Website links

External links

Discussion Group - Google Finance

Description

LIVZON PHARMACEUTICAL GROUP INC. is a China-based company principally engaged in research, development, production and distribution of pharmaceutical products. The Company primarily offers western pharmaceutical preparations, bulk drugs, traditional Chinese medicines (TCMs), as well as diagnostic reagents and equipment. The Company�s western pharmaceutical preparations include various categories such as gastrointestinal, cardiovascular, anti-infectious, antimicrobial, anti-cancer, as well as blood and hemopoietic system, among others. The Company's bulk drugs include Ceftriaxone sodium, Mevastatin, Pravastatin, Cefuroxime, Phenylalanine, Vancomycin and others. It also involves in agency import of other pharmaceutical products. The Company distributes its products within domestic market and to overseas markets.

Officers and directors

Baoguo Zhu Chairman of the Board, President
Age: 50
Guangxia Liu Vice Chairman of the Board
Age: 43
Ning An Executive Vice President, Director
Age: 41
Desheng Tao Vice President, Director
Age: 48
Wenqi Lu Vice President
Age: 45
Guoxiang Xu Vice President
Age: 50
Daihong Yang Vice President
Age: 46
Rucai Li Secretary of the Board
Age: 42
Qingfeng Qiu Director
Age: 41
Shan Zhong Director
Age: 41